Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mytocel MSK vs PRP in Knee Osteoarthritis
NCT07453953Phase 1Not yet recruiting
- Sponsor
- Taichung Veterans General Hospital
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Modality
- Stem Cell Therapies
01
Overview
Phase 1 trial of Mytocel MSK in knee osteoarthritis (OA) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 52 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
Mytocel MSK
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07453953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453953.